Reevaluation of clinical and laboratory standards institute disk diffusion breakpoints for tetracyclines for testing Enterobacteriaceae

Journal of Clinical Microbiology

Volumn 45, Issue 5, 2007, Pages 1640-1643

  Sader, Helio S ^a   Ferraro, Mary J ^b   Reller, L Barth ^c   Schreckenberger, Paul C ^d   Swenson, Jana M ^e   Jones, Ronald N ^a  

^a JMI LABORATORIES   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c DUKE UNIVERSITY   (United States)

^d LOYOLA UNIVERSITY CHICAGO   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; MINOCYCLINE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; ENTEROBACTERIACEAE; INTERMETHOD COMPARISON; LABORATORY TEST; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; LABORATORIES; TETRACYCLINES;

ENTEROBACTERIACEAE;

EID: 34248571276     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00143-07     Document Type: Article

References (19)

1. Agwuh, K. N., and A. MacGowan. 2006. Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J. Antimicrob. Chemother. 58:256-265.
2. Allen, J. C. 1976. Minocycline. Ann. Intern. Med. 85:482-487.
3. Barry, A. L., D. L. Draper, and M. K. Wong. 1978. Aerobic and anaerobic susceptibility tests with three tetracyclines. Reassessment of the "class concept" of disk testing. Am. J. Clin. Pathol. 70:821-825.
4. Bradford, P. A. 2004. Tigecycline: a first in class glycylcycline. Clin. Microbiol. Newslett. 26:163-168.
5. Bryskier, A. 2005. Tetracyclines, p. 642-651. In A. Bryskier (ed.), Antimicrobial agents: antibacterials and antifungals, vol. 1. ASM Press, Washington, DC.
6. Chopra, I., and M. Roberts. 2001. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol. Mol. Biol. Rev. 65:232-260.
7. Clinical and Laboratory Standards Institute. 2006. M2-A9. Performance standards for antimicrobial disk susceptibility tests; approved standard, 9th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Clinical and Laboratory Standards Institute. 2006. M7-A7. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 7th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
9. Clinical and Laboratory Standards Institute. 2006. M100-S16, Performance standards for antimicrobial susceptibility testing; 16th informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA.
10. Clinical and Laboratory Standards Institute. 2007. M100-S17. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA.
11. Cunha, B. A., C. M. Sibley, and A. M. Ristuccia. 1982. Doxycycline. Ther. Drug Monit. 4:115-135.
12. Duggar, B. 1948. Aureomycin, a product of the continuing search for new antibiotics. Ann. N. Y. Acad. Sci. 51:177-181.
13. National Committee for Clinical Laboratory Standards. 1976. Approved standard M2-A. Performance standards for antimicrobic disc susceptibility tests, 1st ed. National Committee for Clinical Laboratory Standards, Villanova, PA.
14. National Committee for Clinical Laboratory Standards. 1979. Approved standard M2-A2. Performance standards for antimicrobic disc susceptibility tests, 2nd ed. National Committee for Clinical Laboratory Standards, Villanova, PA.
15. National Committee for Clinical Laboratory Standards. 1981. First supplement, M2-A2S. Performance standards for antimicrobic disk susceptibility tests, 2nd ed. National Committee for Clinical Laboratory Standards, Villanova, PA.
16. National Committee for Clinical Laboratory Standards. 1982. Second supplement, M2-A2 S2. Performance standards for antimicrobic disk susceptibility tests, 2nd ed. National Committee for Clinical Laboratory Standards, Villanova, PA.
17. National Committee for Clinical Laboratory Standards. 2001. Approved guideline M23-A2. Development of in vitro susceptibility testing criteria and quality control parameters, 2nd ed. National Committee for Clinical Laboratory Standards, Wayne, PA.
18. Neu, H. C. 1978. A symposium on the tetracyclines: a major appraisal. Introduction. Bull. N. Y. Acad. Med. 54:141-155.
19. Woodford, N., P. M. Tierno, Jr., K. Young, L. Tysall, M. F. Palepou, E. Ward, R. E. Painter, D. F. Suber, D. Shungu, L. L. Silver, K. Inglima, J. Kornblum, and D. M. Livermore. 2004. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A β-lactamase, KPC-3, in a New York medical center. Antimicrob. Agents Chemother. 48:4793-4799.